BlackRock’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$789M Buy
28,611,470
+1,430,316
+5% +$39.5M 0.02% 751
2025
Q1
$771M Buy
27,181,154
+1,389,207
+5% +$39.4M 0.02% 750
2024
Q4
$1.07B Buy
25,791,947
+759,934
+3% +$31.6M 0.02% 598
2024
Q3
$1.67B Sell
25,032,013
-530,308
-2% -$35.4M 0.04% 437
2024
Q2
$3.04B Buy
25,562,321
+166,443
+0.7% +$19.8M 0.07% 249
2024
Q1
$2.71B Buy
25,395,878
+94,186
+0.4% +$10M 0.06% 283
2023
Q4
$2.52B Buy
25,301,692
+562,306
+2% +$55.9M 0.06% 284
2023
Q3
$2.56B Buy
24,739,386
+575,675
+2% +$59.5M 0.07% 257
2023
Q2
$2.94B Sell
24,163,711
-929,447
-4% -$113M 0.08% 237
2023
Q1
$3.85B Sell
25,093,158
-1,022,645
-4% -$157M 0.11% 154
2022
Q4
$4.69B Buy
26,115,803
+713,652
+3% +$128M 0.15% 121
2022
Q3
$3B Sell
25,402,151
-815,231
-3% -$96.4M 0.1% 182
2022
Q2
$3.75B Sell
26,217,382
-2,454,553
-9% -$351M 0.12% 152
2022
Q1
$4.94B Buy
28,671,935
+1,010,462
+4% +$174M 0.13% 132
2021
Q4
$7.03B Buy
27,661,473
+779,313
+3% +$198M 0.18% 94
2021
Q3
$10.3B Buy
26,882,160
+7,491,435
+39% +$2.88B 0.29% 56
2021
Q2
$4.56B Sell
19,390,725
-1,412,672
-7% -$332M 0.13% 136
2021
Q1
$2.72B Buy
20,803,397
+326,683
+2% +$42.8M 0.08% 233
2020
Q4
$2.14B Buy
20,476,714
+239,949
+1% +$25.1M 0.07% 280
2020
Q3
$1.43B Buy
20,236,765
+412,616
+2% +$29.2M 0.05% 341
2020
Q2
$1.27B Buy
19,824,149
+7,450,811
+60% +$478M 0.05% 354
2020
Q1
$371M Buy
12,373,338
+649,320
+6% +$19.4M 0.02% 769
2019
Q4
$229M Buy
11,724,018
+3,371,833
+40% +$66M 0.01% 1373
2019
Q3
$133M Buy
8,352,185
+7,690,515
+1,162% +$122M 0.01% 1704
2019
Q2
$9.69M Buy
661,670
+93,239
+16% +$1.36M ﹤0.01% 3235
2019
Q1
$11.6M Buy
568,431
+542,793
+2,117% +$11M ﹤0.01% 3024
2018
Q4
$391K Buy
+25,638
New +$391K ﹤0.01% 4070